Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Treated with Neoadjuvant Chemotherapy”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Ended earlyNCT02795572
What this trial is testing

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Who this might be right for
Peripheral Neuropathy in Breast Cancer Patient
AHS Cancer Control Alberta 13
Not applicableLooking for participantsNCT04373655
What this trial is testing

AXillary Surgery After NeoAdjuvant Treatment

Who this might be right for
Breast Cancer
European Breast Cancer Research Association of Surgical Trialists 3,000
Large-scale testing (Phase 3)Study completedNCT02586025
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel

Who this might be right for
Breast Cancer
Hoffmann-La Roche 329
Large-scale testing (Phase 3)UnknownNCT02249208
What this trial is testing

Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.

Who this might be right for
Breast Cancer
Hospital Universitari Vall d'Hebron Research Institute 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07107217
What this trial is testing

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Blokhin's Russian Cancer Research Center 40
Large-scale testing (Phase 3)UnknownNCT02769104
What this trial is testing

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

Who this might be right for
Neoadjuvant Therapy
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Study completedNCT06513364
What this trial is testing

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd 40
Post-approval studies (Phase 4)UnknownNCT03270007
What this trial is testing

Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 304
Testing effectiveness (Phase 2)Study completedNCT00096291
What this trial is testing

Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT06682195
What this trial is testing

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

Who this might be right for
TNBC, Triple Negative Breast Cancer
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT00513695
What this trial is testing

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Inflammatory Breast CancerMale Breast CancerStage II Breast Cancer+3 more
University of Washington 68
Early research (Phase 1)Study completedNCT00872625
What this trial is testing

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 26
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Not applicableStudy completedNCT01061359
What this trial is testing

Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

Who this might be right for
Breast Neoplasm
Pfizer 1,981
Not applicableStudy completedNCT00808041
What this trial is testing

Chemotherapy Monitoring With Breast Computed Tomography (CT)

Who this might be right for
Breast Cancer
Emory University 3
Not applicableStudy completedNCT00033397
What this trial is testing

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 360
Testing effectiveness (Phase 2)UnknownNCT04197687
What this trial is testing

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Who this might be right for
Breast AdenocarcinomaStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+5 more
Academic and Community Cancer Research United 480
Large-scale testing (Phase 3)UnknownNCT02236806
What this trial is testing

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Who this might be right for
Breast CancerCardiotoxicity
Azienda Ospedaliero-Universitaria Careggi 262
Early research (Phase 1)Study completedNCT04081389
What this trial is testing

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+16 more
Roswell Park Cancer Institute 9
Next Page